InvestorsHub Logo
Followers 6
Posts 372
Boards Moderated 0
Alias Born 03/27/2014

Re: None

Thursday, 09/25/2014 9:56:19 PM

Thursday, September 25, 2014 9:56:19 PM

Post# of 144814
April 1, 2014 was an Exciting Day for Nuvilex: Nuvilex Retains TD2 to Conduct Preclinical and Clinical Studies...Read More in the Main Page of www.td2inc.com
What might Tomorrow Bring? Or the Next Day? Pre-Clinical Trials Results Very Soon from Dr. Daniel Von Hoff. Nuvilex and their "Cell-In-The-Box" Drug-Delivery "Platform" Technology is being Proven and Refined...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News